Yesterday and today were our first Clinical Case Study, using the case-based learning method that is a hallmark of HMS’s New Pathway (now technically the New New Pathway, or the Ever-Renewing New Pathway, or some such). I really enjoyed this unit of the Introduction to the Profession Course.
First, it was more than just small-group sessions, which is what I had thought it would be. Instead, we had two small-group tutorials (90 minutes each) each day, in which we watched short videos of a patient interview with a man with HIV/AIDS talk with his AIDS specialist about everything from the clinical history of his disease (infection sometime in the early 1980s when the first cases were recognized, then full-blown AIDS upon appearance of PCP, pneumocystis carinii pneumonia) to the psychological and social issues he has faced and how his personal identity and sense of self have changed as a result of the disease. We discussed the videos in the small group, each contributing whatever previous knowledge we had plus the topics we had chosen to research further between meetings. We were guided by a wonderful faculty member who struck the perfect balance between guiding/informing us and letting us loose to explore the case. We had two lectures, one on the history of the epidemic and one on translating HIV/AIDS research into clinical practice. Finally, we were afforded the incredible opportunity of meeting the patient and his physician this afternoon. As someone who learns well by learning repeatedly and from multiple sources and in multiple formats, the combination of small-group exploration, individual research (with the help of an orientation from the friendly folks at Countway Library and the ridiculously rich digital resources of the Harvard system), and (high-quality) formal lectures worked really well for me. I felt that I was able to retain information from one “piece” of the case to the next and to establish linkages between things I learned at different times and in different settings. I’m still working on getting the overall big-picture/framework (see previous entry) for HIV/AIDS but I think I’m light-years further along in my knowledge and understanding of something I knew very little about before, and obviously something that is of crucial interest to the healthcare profession and the world in general.
Which leads to the second thing I enjoyed about the case study: the choice of HIV/AIDS as a topic to study. Like perhaps no other illness, HIV/AIDS acts as a point of intersection for all of the things I wrote about in my introductory entry in this journal, and more. Scientifically, it is a devastatingly complex entity encompassing mechanisms of viral transmission and replication, the complicated and sophisticated mechanics of the immune system, and the mutation and the evolution of the virus itself as it has continuously outrun whatever we have done to try to stop it; the challenges and the victories of HIV/AIDS research are pretty amazing to learn about. Medically, it can affect virtually every system of the body either itself or through opportunistic infections; today I researched AIDS-related peripheral neuropathy, numbness/tingling/pain indicative of nerve damage in the feet and caused by either inflammatory responses to the HIV virus itself or by antiretroviral therapies’ toxic effects on mitochondria, which are present in every cell in the body… Emotionally, it can not only produce neuropsychiatric complications (AIDS dementia, depression due to subcortical brain damage) but also obviously serious and complex emotional and psychiatric problems (e.g. depression related not to brain/functional damage but to social isolation, constant stress, etc.) – all very MBB. Socially, there are all the issues of transmission, detection, prevention, stigmatization, education, isolation, community, activism… Our patient also made clear that his individual identity had become inextricably entangled with the disease: he had to reduce to part-time his very high-powered legal career, which had obviously been hugely meaningful to him, in order to take on a new identity or career as a patient with an acute fatal, and then chronic manageable, illness. Changes to his health and to the treatment options available changed everything about how he lived and moved in the world and how he saw himself. The patient himself was just an amazing and inspirational guy; through all of this, watching 90% (he said this) of his friends with the disease die, suffering terrible complications and side effects and quite a few times thinking that he was near death, he has remained incredibly humble and grateful for everything he has. He is doing quite well now on a newer cocktail of drugs, and now he is reaching out to help others in various ways – “What an honor it is to be in a position to help rather than be helped.”
Finally, I’ll leave the reader with some concise advice from the patient in his in-person interview: “Never underestimate the importance of likeability.” In a nutshell, as pithy as it is, that might be the message we are supposed to take from this course: no matter how small or insignificant, or insurmountably hard, it may seem, you have to act like a good human being for your patients to see you as a good doctor, and more importantly for you to be a good doctor. The message is being sent in this class, from the very beginning, that it is not optional to be caring and compassionate. It is not an extra, a special feature, an add-on, or something you can worry about developing with age and experience. It begins now, quite literally in the first week of medical school.
Postscript: I fortuitously read this just after finishing my last edit on the post. Again, my religious learnings tie perfectly to my medical ones, and you may substitute “medicine” for “UUism/religion.” “I suppose what led most of us to Unitarian Universalism is our understanding that the central question of religion is not whether one lives forever but whether one lives.” – Devon Wood